Directorate Changes

UDG HEALTHCARE PLC

Directorate Changes

17 December 2019: UDG Healthcare plc ("UDG Healthcare" or the "Group"), a leading international healthcare services provider, confirms a number of planned board changes.

As previously communicated, Chris Corbin and Chris Brinsmead, both Non-Executive Directors who have each served over nine years on the Board, have informed the Board of their intention to retire during 2020. In early 2019, we appointed Peter Chambré and Shane Cooke in anticipation of these retirements. The Company hereby confirms that both Chris Corbin and Chris Brinsmead will retire at the end of the upcoming Annual General Meeting on 28 January 2020.

Further to previous communications regarding the Board's succession planning, and noting that he has served on the Board since 2004 and as Chair since 2012, Peter Gray, Non-Executive Chair has informed the Board that he intends to step down as Chair of UDG Healthcare in September 2020. A selection process to appoint a new Chair is underway, overseen by the Nominations & Governance Committee and led by Senior Independent Director, Myles Lee. A further update, including the effective date of Mr Gray's departure, will be announced in due course.

Nancy Miller-Rich has also confirmed her intention not to seek re-election at the upcoming Annual General Meeting on 28 January 2020 and a search for a replacement has been commenced.

Peter Gray, Chair of UDG Healthcare commented: "I would like to take this opportunity to express our sincere thanks to Chris Corbin, Chris Brinsmead and Nancy Miller-Rich for their significant contribution to UDG Healthcare during their tenure and I wish them well in their future endeavours."

For further information, please contact:

UDG Healthcare plc

Damien Moynagh

General Counsel & Company Secretary

+353 (1) 468 9000

Business / Financial media:

Powerscourt

Lisa Kavanagh / Jack Hickey

Tel: + 44-207-250-1446

[email protected]

Ends.

About UDG Healthcare plc

UDG Healthcare plc (LON: UDG) is a leading international partner of choice delivering advisory, communication, commercial, clinical and packaging services to the healthcare industry, employing 8,700 people with operations in 26 countries and delivering services in over 50 countries.

UDG Healthcare plc operates across two divisions: Ashfield and Sharp.

Ashfield - Ashfield is a global leader in commercialisation services for the pharmaceutical and healthcare industry, operating across three broad areas of activity: advisory, communications and commercial & clinical services. It focuses on supporting healthcare professionals and patients at all stages of the product life cycle. The division provides field and contact centre sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services to over 300 healthcare companies.

Sharp - Sharp is a global leader in contract commercial packaging and clinical trial packaging services for the pharmaceutical and biotechnology industries, operating from state-of-the-art facilities in the US and Europe.

The company is listed on the London Stock Exchange and is a constituent of the FTSE 250.

For more information, please go to: www.udghealthcare.com